ZA873338B - Process for isolating and purifying p. falciparium cs protein vaccine expressed in recombinant e. coli - Google Patents

Process for isolating and purifying p. falciparium cs protein vaccine expressed in recombinant e. coli

Info

Publication number
ZA873338B
ZA873338B ZA873338A ZA873338A ZA873338B ZA 873338 B ZA873338 B ZA 873338B ZA 873338 A ZA873338 A ZA 873338A ZA 873338 A ZA873338 A ZA 873338A ZA 873338 B ZA873338 B ZA 873338B
Authority
ZA
South Africa
Prior art keywords
falciparium
coli
recombinant
purifying
isolating
Prior art date
Application number
ZA873338A
Other languages
English (en)
Inventor
Peter Arletti Dephillips
Arletti Dephillips Peter
Gail Marie Folena Wasserman
Marie Folena Wasserman Gail
Robert David Sitrin
David Sitrin Robert
Dane William Zabriskie
William Zabriskie Dane
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZA873338B publication Critical patent/ZA873338B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA873338A 1986-05-12 1987-05-11 Process for isolating and purifying p. falciparium cs protein vaccine expressed in recombinant e. coli ZA873338B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86181086A 1986-05-12 1986-05-12

Publications (1)

Publication Number Publication Date
ZA873338B true ZA873338B (en) 1988-07-27

Family

ID=25336830

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA873338A ZA873338B (en) 1986-05-12 1987-05-11 Process for isolating and purifying p. falciparium cs protein vaccine expressed in recombinant e. coli

Country Status (8)

Country Link
EP (1) EP0252588A3 (ja)
JP (1) JPH01502556A (ja)
AU (1) AU603586B2 (ja)
DK (1) DK10288A (ja)
FI (1) FI885237A0 (ja)
PT (1) PT84850B (ja)
WO (1) WO1987006939A1 (ja)
ZA (1) ZA873338B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289129A3 (en) * 1987-03-26 1990-10-10 Repligen Corporation High purity protein a preparation
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it
US6093406A (en) * 1988-06-02 2000-07-25 The United States Of America As Represented By The Secretary Of The Army Vaccine for induction of immunity to malaria
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
JPH0687974B2 (ja) * 1990-03-27 1994-11-09 忠一 平山 発熱物質の吸着材料
US5612454A (en) * 1990-03-30 1997-03-18 Shiseido Company Ltd. Process for purification of polypeptide using a buchner funnel
AU2003270380B2 (en) 2002-09-06 2010-07-01 Genentech, Inc. Process for protein extraction
WO2005097986A1 (en) * 2004-04-02 2005-10-20 Roche Diagnosticss Gmbh Highly purified proteinase k
US20100273983A1 (en) * 2007-04-05 2010-10-28 The University Of Queensland Method of purifying peptides by selective precipitation
US9115205B2 (en) 2010-10-18 2015-08-25 The United States Of America, As Represented By The Secretary Of The Army Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
EP3625334A1 (en) * 2017-05-15 2020-03-25 c-LEcta GmbH Enzyme products
BR112022006537A2 (pt) * 2019-11-07 2022-07-05 Nutricia Nv Processo para preparar um hidrolisado de proteína de soro do leite ultrafiltrado, hidrolisados de proteína de soro do leite ultrafiltrado, composição de hidrolisado de proteína de soro do leite, composições nutricionais, uso da composição nutricional e uso do hidrolisado de proteína de soro do leite ultrafiltrado

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
ZW2485A1 (en) * 1984-02-22 1986-09-24 Wellcome Found Cloning of dna for protozoal antigens
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
ATE78869T1 (de) * 1985-02-07 1992-08-15 Smithkline Beecham Corp Malaria-impfstoff.

Also Published As

Publication number Publication date
EP0252588A3 (en) 1989-07-12
DK10288D0 (da) 1988-01-11
EP0252588A2 (en) 1988-01-13
PT84850B (pt) 1990-02-08
DK10288A (da) 1988-01-11
PT84850A (en) 1987-06-01
FI885237A (fi) 1988-11-11
JPH01502556A (ja) 1989-09-07
AU7440087A (en) 1987-12-01
FI885237A0 (fi) 1988-11-11
AU603586B2 (en) 1990-11-22
WO1987006939A1 (en) 1987-11-19

Similar Documents

Publication Publication Date Title
GB8721424D0 (en) Recombinant expression method
AU2964489A (en) Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
EP0293394A4 (en) NEW THROMBOLYTIC PROTEINS.
ZA873338B (en) Process for isolating and purifying p. falciparium cs protein vaccine expressed in recombinant e. coli
GB8719963D0 (en) Recombinant dna products
EP0209543A4 (en) FRAGMENTS OF HUMAN APOLIPOPROTEINS PEPTIDES, TYPE-SPECIFIC ANTIBODIES AND METHODS OF USE.
EP0264819A3 (en) Variant aequorin genes and process for producing variant aequorin proteins
GB8823068D0 (en) Recombinant dna
PT85461A (en) Process for preparing recombinant htlv-iii proteins and uses thereof
NZ233672A (en) Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence
ZA882272B (en) Immunogenic recombinant yeast expression product and method for purifying it
IL86153A0 (en) Recombinant htlv-iii proteins and uses thereof
EP0242359A4 (en) CLONING CARRIER FOR CLONING A LARGE DNA FRAGMENT AND VACCINE CONTAINING 987P FIMRIAL PROTEIN.
IL85239A0 (en) Recombinant alveolar surfactant protein,its production and purification and pharmaceutical compositions containing it
PT86162A (en) Recombinant protein expression
IE871212L (en) "process for isolating and purifying p. falciparum cs¹protein vaccine expressed in recombinant e. colt"
AU571460B2 (en) Alpha interferon dna, recombinant plasmid, engineered organism and alpha interferon polypeptide
EP0288901A3 (en) Recombinant human glutathione peroxidase, process for preparing the same and dna coding the same
IL86699A0 (en) Cell system for expression of recombinant protein without production of virus
KR880009039A (ko) 재조합 α-인터페론의 정제방법
GB8623925D0 (en) Recombinant dna methods
GB8729970D0 (en) Recombinant dna for use in yeast
IE873131L (en) Recombinant protein expression.
GB8728975D0 (en) Purification of recombinant protein
GB8631071D0 (en) Recombinant dna